LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens

We have previously shown that through the production of high LIGHT levels, immune cells contribute to both osteoclastogenesis and bone destruction in Multiple Myeloma (MM)-related bone disease. With the aim of further exploring the mechanisms underlying the development of MM-related bone disease, he...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Brunetti, Giacomina, Rizzi, Rita, Storlino, Giuseppina, Bortolotti, Sara, Colaianni, Graziana, Sanesi, Lorenzo, Lippo, Luciana, Faienza, Maria Felicia, Mestice, Anna, Curci, Paola, Specchia, Giorgina, Grano, Maria, Colucci, Silvia
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206078/
https://ncbi.nlm.nih.gov/pubmed/30405638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02459
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados